Related Experiment Video
Updated: Feb 10, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
The concordance between upper and lower respiratory microbiota in children with Mycoplasma pneumoniae pneumonia
Wenkui Dai1, Heping Wang2, Qian Zhou3
1Department of Computer Science, City University of Hong Kong, 999077, Hong Kong, China.
Abstract:
In recent years, the morbidity of Mycoplasma pneumoniae pneumonia (MPP) has dramatically increased in China. An increasing number of studies indicate that an imbalance in the respiratory microbiota is associated with respiratory infection. We selected 28 hospitalized patients infected with M. pneumoniae and 32 healthy children. Nasopharyngeal (NP) and oropharyngeal (OP) swabs were collected from healthy children, whereas NP, OP and bronchoalveolar lavage (BAL) specimens were collected from patients. Microbiota analysis was performed on all microbial samples using 16 S ribosomal RNA (16 S rRNA) sequencing. The NP microbial samples in healthy children were divided into two groups, which were dominated by either Staphylococcus or mixed microbial components. The respiratory microbiota in pneumonia patients harbored a lower microbial diversity compared to healthy children, and both the NP and OP microbiota of patients differed significantly from that of healthy children. Hospitalized MPP children with a higher abundance of Mycoplasma in the BAL fluid (BALF) microbiota tended to suffer longer hospitalization lengths and higher peak fevers and serum C-reactive protein levels. Concordance analysis explained the succession of imbalanced NP microbiota to the OP and lung in diseased children. However, the association of the abundance of Mycoplasma in BALF microbiota with that in NP or OP microbiota varied among individuals, which suggested the sensitivity of BALF in MPP diagnostics, mirroring MPP severity.
Insights
Mycoplasma pneumoniae pneumonia (MPP) is linked to respiratory microbiota imbalance. In children with MPP, lower microbial diversity and specific bacterial shifts were observed, correlating with disease severity.
Area of Science:
- Microbiology
- Pediatric Infectious Diseases
- Respiratory Medicine
Background:
- Mycoplasma pneumoniae pneumonia (MPP) morbidity is rising, particularly in China.
- Respiratory microbiota imbalance is increasingly implicated in respiratory infections.
- Understanding the role of microbiota in MPP pathogenesis is crucial.
Purpose of the Study:
- To investigate the differences in respiratory microbiota between children with MPP and healthy children.
- To explore the relationship between microbiota composition and MPP severity.
- To analyze the succession of microbiota from the nasopharynx to the lower respiratory tract in MPP patients.
Main Methods:
- 16S ribosomal RNA (16S rRNA) sequencing was used for microbiota analysis.
- Samples included nasopharyngeal (NP), oropharyngeal (OP), and bronchoalveolar lavage (BAL) specimens.
- Comparison was made between 28 hospitalized MPP patients and 32 healthy children.
Main Results:
- Pneumonia patients exhibited lower respiratory microbial diversity compared to healthy children.
- Significant differences were found in NP and OP microbiota between patients and healthy controls.
- Higher Mycoplasma abundance in BAL fluid correlated with longer hospitalization, higher fever, and elevated C-reactive protein levels.
Conclusions:
- MPP is associated with significant alterations in the respiratory microbiota.
- The study suggests a progression of microbiota imbalance from the upper to the lower respiratory tract in MPP.
- BAL fluid microbiota analysis shows promise for diagnosing MPP severity.
More Related Videos
13:27Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Anatomy of Respiratory System I: Upper Respiratory Tract
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....